Clinical trial Recruiting at 1 site Observational Ages 6 and up

Evaluating music and voice skills in cochlear implant users

Official title: Analysis of Musical and Voice Skills in Children and Adult Cochlear Implant Users

Run by Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz · NCT05319678 · Data updated 2026-11-12

This study is testing how well kids and adults with cochlear implants enjoy and understand music compared to people with normal hearing.

Quick facts

Study typeObservational
Ages6 Years and up
SexAll
Enrollment80 (estimated)
SponsorFundacion para la Investigacion Biomedica del Hospital Universitario la Paz
Academic / other
Locations1 site (Madrid, Madrid)
StatusRecruiting
StartedFebruary 10, 2022
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedAugust 12, 2025
Trial IDNCT05319678 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children aged 6-17 who were implanted before age 3 and postlingual adults with at least 12 months of CI experience.

Probably not a fit

Patients who do not meet the inclusion criteria, such as those with additional disabilities or prelingual adults, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the perception and enjoyment of music among cochlear implant (CI) users, comparing their results with a control group of individuals with normal hearing. Participants will be evaluated using specific questionnaires and the Meludia music software to analyze their musical abilities. Additionally, a voice analysis will be conducted to explore any associations between musical perception and voice quality. The study will include children aged 6 to 17 years who received their CI before age 3, as well as postlingual adults who have undergone cochlear implantation since 2000.

Why it matters

Potential benefit: If successful, this study could enhance understanding of musical and vocal skills in cochlear implant users, potentially leading to improved rehabilitation strategies.

How similar studies have gone: While there is limited data on similar studies, the approach of evaluating musical perception in CI users is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Minimum age of 6 years.
* Patients aged 6-17 years must have been implanted before the age of 3 years (to ensure adequate CI performance).
* Minimum 12 months experience with the device
* Indications: unilateral (one CI), bilateral (two CIs), bimodal (one CI in one ear and a hearing aid in the other)
* At least 80% of electrodes active at the time of assessment.
* Fluency in Spanish
* Signed and dated informed consent prior to starting any study procedure.

Exclusion Criteria:

* Not meet inclusion criteria.
* Prelingual or perilingual adults.
* Disability in addition to hearing impairment (e.g., mental disability).

Where it's running

  • Hospital Universitario de La Paz
    Madrid, Madrid, Spain
    Recruiting

Study contacts

  • Principal investigator: Luis Lassaletta — Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
  • Study coordinator: Luis Lassaletta
  • Email: llasaletta@salud.madrid.org
  • Phone: +34917277262

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.